美国STAAR Surgical Company 
公司成立于1982年，总部位于美国加利福尼亚州，瑞士为其生产基地。STAAR瑞士公司出品的具有独家专利保护的COLLAMER屈光晶体（ICL）是目前全球唯一已经通过美国FDA、欧洲Ce及中国SFDA认证的 可植入式后房隐形屈光接触镜。

STAARSurgical公司ICL植入手术开展有十余年历史。1997年获准在欧洲市场使用ICL开展视力矫正手术；2005年美国食品及药物管理局（FDA）批准应用Visian ICL降低和治疗近视；2006年8月ICL被中国SFDA正式批准使用。公司最新型号VISIAN　ICL－V4已经在全世界范围内广泛使用，手术总数超过八万例，其中中国已完成了超过500例ICL手术。

VisianICL因术后极佳的视觉质量、可逆性（容易取出和替换）、保留自然的角膜组织完整、手术简单、快捷、安全等突出优点为单纯近视、近视伴散光以及远视的矫正提供了一种全新的手术方法和理念。因而ICL用于治疗各种高中度近视、远视及散光，超越了激光治疗的极限，是替代LASIK手术的最新、最安全的产品，具备广阔的发展前景。

Enhancing Surgical Eye Correction with Collamer® IOLs and other Advancements
STAAR Surgical Company is at the vanguard of minimally invasive ophthalmic vision enhancement and technology. We believe in the importance of improving the efficiency, convenience, and comfort of corrective eye surgery for both medical professionals and patients. It is for this reason that we continually evaluate our existing products to ensure that we are providing the latest cataract, refractive error, and glaucoma treatments. From our patented COLLAMER lenses to Cruise Control, our unique new high vacuum surgery system, STAAR Surgical Company is responsible for some of the most revolutionary developments in ophthalmology.

Regarded as a technology leader in the surgical eye correction industry, STAAR Surgical Company was founded in 1982 when the intraocular lens (IOL) was still in its relative infancy. Although still an integral part of the company's portfolio, STAAR Surgical Company's product lines have expanded beyond cataract correction solutions to include lenses and medical devices for refractive and glaucoma surgery.

STAAR Surgical Company has revolutionized the industry with its development and use of Collamer. This unique lens material is used in the Afinity™ line of intraocular lenses (IOLs), the Visian ICL, and the Visian TICL*. Each Collamer lens produced by STAAR Surgical Company is made from a material that not only is durable, but also replicates features of the eye's natural lens, creating high quality of vision and optimal biocompatibility.

STAAR Surgical Company has developed into a global surgical eye correction technology leader. To foster ongoing growth, we emphasize creativity, research, and development. Using these tools, STAAR Surgical Company plans to continue making advancements in technology, marketing, and financial strength.